🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    Bioprotect

    Now a part of Olympus, this medical technology company manufactures a biodegradable balloon spacer designed to protect the rectum during prostate cancer radiation therapy. The device creates a uniform, symmetrical space between the prostate and the anterior rectal wall to reduce radiation dose delivery to healthy tissue. The product is used by radiation oncologists and urologists performing SBRT, brachytherapy, and conventional radiotherapy treatments.

    Visit websiteTsur Moshe, IsraelFounded 2004
    Healthtech
    Medical Devices
    Oncology

    Funding summary

    Total raised
    €32.8M
    Funding rounds
    2

    Investors in Bioprotect

    Investors on record for Bioprotect. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like Bioprotect?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy